扩张型、肥厚型及正常心脏的收缩期心肌容积增加:心脏磁共振研究
研究纳入健康个体30例及肥厚型心肌病110例、扩张型心肌病89例、主动脉瓣狭窄78例,用心脏磁共振计算左心室功能及舒张末期、收缩末期容积。结果显示所有组收缩末期心肌容积均高于舒张末期,肥厚型心肌病和主动脉瓣狭窄的收缩期容积增加大于健康个体,扩张型心肌病小于肥厚型心肌病和主动脉瓣狭窄。
要点
- 健康个体及肥厚型心肌病、扩张型心肌病、主动脉瓣狭窄患者收缩末期心肌容积均高于舒张末期。
- 肥厚型心肌病和主动脉瓣狭窄的收缩期心肌容积增加百分比高于健康个体。
- 扩张型心肌病的收缩期心肌容积增加百分比低于肥厚型心肌病和主动脉瓣狭窄。
核心结论
- 所有患者亚组的收缩末期心肌容积均显著高于舒张末期容积,肥厚心脏的收缩期容积增加大于非肥厚心脏。
研究设计与样本
- 研究纳入健康个体30例及肥厚型心肌病110例、扩张型心肌病89例、主动脉瓣狭窄78例,基于心脏磁共振计算左心室功能及舒张末期、收缩末期容积。
诊断标准与关键数值
- 健康个体收缩末期心肌容积91.2±26.6 ml vs 舒张末期85.1±24.3 ml,p<0.001。
- 肥厚型心肌病收缩末期心肌容积214.3±81.6 ml vs 舒张末期176±64.2 ml,p<0.01。
- 扩张型心肌病收缩末期心肌容积128.4±43.1 ml vs 舒张末期115.4±42.9 ml,p<0.001。
- 主动脉瓣狭窄收缩末期心肌容积155.1±37.1 ml vs 舒张末期129.4±34.6 ml,p<0.001。
- 收缩期容积增加百分比:肥厚型心肌病21.5±8.3% vs 健康个体10.6±6.3%,p<0.01;主动脉瓣狭窄18.3±5.7% vs 健康个体10.6±6.3%,p=0.013;扩张型心肌病11.2±4.8% vs 肥厚型心肌病21.5±8.3%,p=0.01;扩张型心肌病11.2±4.8% vs 主动脉瓣狭窄18.3±5.7%,p=0.02;主动脉瓣狭窄与肥厚型心肌病比较p=ns;扩张型心肌病与健康个体比较p=ns。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate changes in myocardial tissue volume during the cardiac cycle to verify the hypothesis of non-compressibility of the myocardium in healthy individuals (HI) as well as in patients with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and aortic stenosis (AS).
MATERIALS AND METHODS: The study group included 30 HI, and patients with HCM (n=110), DCM (n=89), and AS (n=78). Left ventricular (LV) function, end-diastolic, and end-systolic volumes were calculated based on cardiac magnetic resonance imaging (CMR) for all participants.
RESULTS: End-systolic myocardial volumes were higher than end-diastolic in both controls (91.2±26.6 versus 85.1±24.3 ml, p<0.001) and in all patient groups: HCM (214.3±81.6 versus 176±64.2 ml, p<0.01), DCM (128.4±43.1 versus 115.4±42.9 ml, p<0.001) and AS (155.1±37.1 versus 129.4±34.6 ml, p<0.001). HCM and AS patients had significantly higher systolic volume gain than HI (21.5±8.3 versus 10.6±6.3%, p<0.01 and 18.3±5.7 versus 10.6±6.3% p=0.013, respectively). Conversely, DCM patients had lesser increases in myocardial systolic volume than HCM patients (11.2±4.8% versus 21.5±8.3, p=0.01) and AS patients (11.2±4.8% versus 18.3±5.7, p=0.02). No differences were found in systolic volume gain between AS and HCM patients (p=ns) or between DCM patients and HI (p=ns).
CONCLUSION: End-systolic myocardial volume was significantly higher than end-diastolic volume in all subsets of patients. The systolic volume gain was greater in individuals with hypertrophy than in those without.
引用
- Mazurkiewicz Ł, Orłowska-Baranowska E, Petryka J, et al. Systolic myocardial volume gain in dilated, hypertrophied and normal heart. CMR study. Clin Radiol. 2017. PMID: 28069158. doi:10.1016/j.crad.2016.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。